Mortality impact of less-than-standard therapy in older breast cancer patients

The purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus radiation therapy (RT), mastectomy, and the receipt of adjuvant tamoxifen in a large population-based cohort of older women with early-stage disea...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American College of Surgeons Ročník 206; číslo 1; s. 66
Hlavní autoři:	Yood, Marianne Ulcickas, Owusu, Cynthia, Buist, Diana S M, Geiger, Ann M, Field, Terry S, Thwin, Soe Soe, Lash, Timothy L, Prout, Marianne N, Wei, Feifei, Quinn, Virginia P, Frost, Floyd J, Silliman, Rebecca A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.01.2008
Témata:	Aged Aged, 80 and over Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - therapy Female Follow-Up Studies Humans Mastectomy - methods Neoplasm Staging Proportional Hazards Models Radiotherapy, Adjuvant - methods Retrospective Studies Survival Rate - trends Tamoxifen - therapeutic use Treatment Outcome United States - epidemiology United States
ISSN:	1879-1190, 1879-1190
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	The purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus radiation therapy (RT), mastectomy, and the receipt of adjuvant tamoxifen in a large population-based cohort of older women with early-stage disease. This cohort study was conducted within six US integrated health-care delivery systems. Automated administrative databases, medical records, and tumor registries were used to identify women aged 65 years or older who received BCS or mastectomy to treat stage I or II breast cancer diagnosed from January 1, 1990, through December 31, 1994. We compared cause-specific 10-year mortality rates across treatment categories by fitting Cox proportional hazards models adjusted for demographics and tumor characteristics. We identified 1,837 women having operations for stage I or II breast cancer. Compared with women receiving mastectomy, those receiving BCS without RT were twice as likely to die of breast cancer (adjusted hazards ratio [HR]=2.19, 95% confidence interval [CI], 1.51 to 3.18). Breast cancer mortality rates were similar between women receiving BCS plus RT and women receiving mastectomy (adjusted HR=1.08, 95% CI, 0.79 to 1.48). In the subset of 886 chemotherapy-naive women treated with tamoxifen, those treated with tamoxifen for less than 1 year had a substantially higher breast cancer mortality rate than those exposed 5 years or more (adjusted HR=6.26, 95% CI, 3.10 to 12.64). Our findings indicate that older women receiving BCS alone have higher rates of breast cancer death than those receiving BCS + RT or mastectomy and that the survival benefit from tamoxifen increases with increasing duration of treatment.
AbstractList	The purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus radiation therapy (RT), mastectomy, and the receipt of adjuvant tamoxifen in a large population-based cohort of older women with early-stage disease.BACKGROUNDThe purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus radiation therapy (RT), mastectomy, and the receipt of adjuvant tamoxifen in a large population-based cohort of older women with early-stage disease.This cohort study was conducted within six US integrated health-care delivery systems. Automated administrative databases, medical records, and tumor registries were used to identify women aged 65 years or older who received BCS or mastectomy to treat stage I or II breast cancer diagnosed from January 1, 1990, through December 31, 1994. We compared cause-specific 10-year mortality rates across treatment categories by fitting Cox proportional hazards models adjusted for demographics and tumor characteristics.STUDY DESIGNThis cohort study was conducted within six US integrated health-care delivery systems. Automated administrative databases, medical records, and tumor registries were used to identify women aged 65 years or older who received BCS or mastectomy to treat stage I or II breast cancer diagnosed from January 1, 1990, through December 31, 1994. We compared cause-specific 10-year mortality rates across treatment categories by fitting Cox proportional hazards models adjusted for demographics and tumor characteristics.We identified 1,837 women having operations for stage I or II breast cancer. Compared with women receiving mastectomy, those receiving BCS without RT were twice as likely to die of breast cancer (adjusted hazards ratio [HR]=2.19, 95% confidence interval [CI], 1.51 to 3.18). Breast cancer mortality rates were similar between women receiving BCS plus RT and women receiving mastectomy (adjusted HR=1.08, 95% CI, 0.79 to 1.48). In the subset of 886 chemotherapy-naive women treated with tamoxifen, those treated with tamoxifen for less than 1 year had a substantially higher breast cancer mortality rate than those exposed 5 years or more (adjusted HR=6.26, 95% CI, 3.10 to 12.64).RESULTSWe identified 1,837 women having operations for stage I or II breast cancer. Compared with women receiving mastectomy, those receiving BCS without RT were twice as likely to die of breast cancer (adjusted hazards ratio [HR]=2.19, 95% confidence interval [CI], 1.51 to 3.18). Breast cancer mortality rates were similar between women receiving BCS plus RT and women receiving mastectomy (adjusted HR=1.08, 95% CI, 0.79 to 1.48). In the subset of 886 chemotherapy-naive women treated with tamoxifen, those treated with tamoxifen for less than 1 year had a substantially higher breast cancer mortality rate than those exposed 5 years or more (adjusted HR=6.26, 95% CI, 3.10 to 12.64).Our findings indicate that older women receiving BCS alone have higher rates of breast cancer death than those receiving BCS + RT or mastectomy and that the survival benefit from tamoxifen increases with increasing duration of treatment.CONCLUSIONSOur findings indicate that older women receiving BCS alone have higher rates of breast cancer death than those receiving BCS + RT or mastectomy and that the survival benefit from tamoxifen increases with increasing duration of treatment. The purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus radiation therapy (RT), mastectomy, and the receipt of adjuvant tamoxifen in a large population-based cohort of older women with early-stage disease. This cohort study was conducted within six US integrated health-care delivery systems. Automated administrative databases, medical records, and tumor registries were used to identify women aged 65 years or older who received BCS or mastectomy to treat stage I or II breast cancer diagnosed from January 1, 1990, through December 31, 1994. We compared cause-specific 10-year mortality rates across treatment categories by fitting Cox proportional hazards models adjusted for demographics and tumor characteristics. We identified 1,837 women having operations for stage I or II breast cancer. Compared with women receiving mastectomy, those receiving BCS without RT were twice as likely to die of breast cancer (adjusted hazards ratio [HR]=2.19, 95% confidence interval [CI], 1.51 to 3.18). Breast cancer mortality rates were similar between women receiving BCS plus RT and women receiving mastectomy (adjusted HR=1.08, 95% CI, 0.79 to 1.48). In the subset of 886 chemotherapy-naive women treated with tamoxifen, those treated with tamoxifen for less than 1 year had a substantially higher breast cancer mortality rate than those exposed 5 years or more (adjusted HR=6.26, 95% CI, 3.10 to 12.64). Our findings indicate that older women receiving BCS alone have higher rates of breast cancer death than those receiving BCS + RT or mastectomy and that the survival benefit from tamoxifen increases with increasing duration of treatment.
Author	Geiger, Ann M Thwin, Soe Soe Field, Terry S Frost, Floyd J Prout, Marianne N Buist, Diana S M Lash, Timothy L Silliman, Rebecca A Yood, Marianne Ulcickas Wei, Feifei Owusu, Cynthia Quinn, Virginia P
Author_xml	– sequence: 1 givenname: Marianne Ulcickas surname: Yood fullname: Yood, Marianne Ulcickas organization: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA – sequence: 2 givenname: Cynthia surname: Owusu fullname: Owusu, Cynthia – sequence: 3 givenname: Diana S M surname: Buist fullname: Buist, Diana S M – sequence: 4 givenname: Ann M surname: Geiger fullname: Geiger, Ann M – sequence: 5 givenname: Terry S surname: Field fullname: Field, Terry S – sequence: 6 givenname: Soe Soe surname: Thwin fullname: Thwin, Soe Soe – sequence: 7 givenname: Timothy L surname: Lash fullname: Lash, Timothy L – sequence: 8 givenname: Marianne N surname: Prout fullname: Prout, Marianne N – sequence: 9 givenname: Feifei surname: Wei fullname: Wei, Feifei – sequence: 10 givenname: Virginia P surname: Quinn fullname: Quinn, Virginia P – sequence: 11 givenname: Floyd J surname: Frost fullname: Frost, Floyd J – sequence: 12 givenname: Rebecca A surname: Silliman fullname: Silliman, Rebecca A
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/18155570$$D View this record in MEDLINE/PubMed
BookMark	eNpNkE1LxDAYhIMo7of-BakXb61v2qZpj7L4Bate9FzeJm_dLmlak_Sw_96KKwgDMwMPc5gVO7WDJcauOSQceHG7T_bYq8EYP7nPJAWQyY-4OGFLXsoq5ryC0395wVbe7wG4hKo4ZwteciGEhCV7fRlcQNOFQ9T1I6oQDW1kyPs47NDGPqDV6HQUduRwnCEbDUaTixpH6EOk0Kq5jRg6ssFfsLMWjafLo6_Zx8P9--Yp3r49Pm_utrHKCwhxCU3WFHnRUi5FU5CGVCme8rzNJEDVQK4yrmXWZqQaXpbYEuoyFxqFliWqdM1ufndHN3xN5EPdd16RMWhpmHwt5zOqXGQzeHUEp6YnXY-u69Ed6r8H0m-f5GRO
CitedBy_id	crossref_primary_10_2217_cer_14_83 crossref_primary_10_1245_s10434_014_4290_5 crossref_primary_10_4048_jbc_2024_0190 crossref_primary_10_1016_j_ctim_2012_04_002 crossref_primary_10_1093_jnci_djp038 crossref_primary_10_1245_s10434_012_2825_1 crossref_primary_10_1200_JCO_2016_67_7336 crossref_primary_10_1016_j_jval_2013_02_006 crossref_primary_10_1177_000313481708300842 crossref_primary_10_2217_ahe_11_24 crossref_primary_10_1016_j_ejso_2020_10_008 crossref_primary_10_1093_annonc_mdv251 crossref_primary_10_3390_ijms232113604 crossref_primary_10_1245_s10434_013_3374_y crossref_primary_10_1136_bmjopen_2020_041626 crossref_primary_10_1007_s11764_009_0107_0 crossref_primary_10_1080_03630242_2015_1061095 crossref_primary_10_1007_s00129_010_2642_1 crossref_primary_10_1016_j_ijsu_2014_08_344 crossref_primary_10_1245_s10434_021_09777_3 crossref_primary_10_1016_j_clbc_2023_01_012 crossref_primary_10_1007_s00520_012_1450_7 crossref_primary_10_1245_s10434_018_6617_0 crossref_primary_10_1007_s10549_020_05684_5 crossref_primary_10_1007_s00520_022_07156_6 crossref_primary_10_1016_j_ejso_2015_01_028 crossref_primary_10_1245_s10434_022_12237_1 crossref_primary_10_1590_0102_311X00114214 crossref_primary_10_1590_1413_81232015203_07982014 crossref_primary_10_1016_j_critrevonc_2009_09_007 crossref_primary_10_1016_j_surg_2024_08_045 crossref_primary_10_1038_bjc_2013_116 crossref_primary_10_1038_s41598_019_40072_0 crossref_primary_10_1016_j_clbc_2015_02_005 crossref_primary_10_1097_MLR_0000000000001019 crossref_primary_10_1007_s10549_019_05353_2 crossref_primary_10_1136_bmjopen_2022_069971 crossref_primary_10_1016_j_clbc_2024_05_002 crossref_primary_10_3390_jpm5030229 crossref_primary_10_1007_s10549_020_05912_y crossref_primary_10_1200_JCO_2014_58_3062 crossref_primary_10_1093_tbm_ibx061 crossref_primary_10_1200_JCO_2008_18_3459 crossref_primary_10_1007_s00520_015_2698_5 crossref_primary_10_1016_j_ctrv_2021_102264 crossref_primary_10_1038_bjc_2013_464 crossref_primary_10_1016_j_ijsu_2016_05_045 crossref_primary_10_1080_07347332_2021_1955318 crossref_primary_10_1148_rg_220166 crossref_primary_10_1002_cncr_25821 crossref_primary_10_1007_s10549_013_2499_9 crossref_primary_10_1038_sj_bjc_6604758 crossref_primary_10_1245_s10434_021_09839_6 crossref_primary_10_1200_JCO_2009_25_9655 crossref_primary_10_1007_s00520_022_06848_3 crossref_primary_10_1002_cncr_34409 crossref_primary_10_1200_EDBK_156682 crossref_primary_10_14694_EdBook_AM_2013_33_271 crossref_primary_10_1016_j_jclinepi_2009_03_001 crossref_primary_10_1002_cncr_26505 crossref_primary_10_1016_j_ejca_2018_03_014 crossref_primary_10_1200_JCO_2008_19_4928 crossref_primary_10_2147_PPA_S296747 crossref_primary_10_1245_s10434_016_5368_z crossref_primary_10_2217_pgs_12_29 crossref_primary_10_1016_j_surg_2022_05_026 crossref_primary_10_1007_s10552_012_0115_7 crossref_primary_10_2217_bmt_14_48 crossref_primary_10_1016_j_breast_2025_104476 crossref_primary_10_1148_radiol_14140209 crossref_primary_10_1016_j_amjsurg_2020_12_029 crossref_primary_10_1093_bjsopen_zrae040 crossref_primary_10_1186_1471_2482_13_S2_S2 crossref_primary_10_1002_cncr_32976 crossref_primary_10_1002_jso_21799 crossref_primary_10_1016_j_clinimag_2025_110467 crossref_primary_10_1016_j_suronc_2009_07_004 crossref_primary_10_1002_cncr_31241 crossref_primary_10_1245_s10434_013_2918_5 crossref_primary_10_1245_s10434_022_12133_8 crossref_primary_10_1186_2193_1801_3_282 crossref_primary_10_1007_s10549_010_1132_4 crossref_primary_10_1158_1940_6207_CAPR_11_0442 crossref_primary_10_1007_s10880_020_09750_4 crossref_primary_10_1586_era_09_67 crossref_primary_10_1111_j_1532_5415_2009_02506_x crossref_primary_10_1186_1471_2407_13_434 crossref_primary_10_1200_JCO_2009_25_9796 crossref_primary_10_1007_s12529_020_09908_2 crossref_primary_10_1200_JCO_2010_33_3179 crossref_primary_10_1136_bmjopen_2021_052146 crossref_primary_10_1007_s12032_015_0599_6 crossref_primary_10_1089_whr_2020_0094 crossref_primary_10_1111_jep_12819 crossref_primary_10_3389_fonc_2023_1287253 crossref_primary_10_1007_s10549_013_2710_z crossref_primary_10_1158_1940_6207_CAPR_13_0389 crossref_primary_10_1016_j_clbc_2019_01_007 crossref_primary_10_1080_20476965_2018_1440925 crossref_primary_10_1186_s40814_022_00985_6 crossref_primary_10_3390_cancers16193317 crossref_primary_10_1016_j_clon_2008_11_012 crossref_primary_10_1097_COC_0000000000000314 crossref_primary_10_1002_pds_4012 crossref_primary_10_1016_j_ijrobp_2017_01_228 crossref_primary_10_1007_s10549_013_2517_y crossref_primary_10_1200_JCO_2008_19_2419 crossref_primary_10_1093_annonc_mdr330 crossref_primary_10_1007_s10549_013_2720_x crossref_primary_10_1016_j_ejso_2018_02_011 crossref_primary_10_1002_cncr_23447 crossref_primary_10_1007_s10549_020_05748_6 crossref_primary_10_1093_jnci_dju319 crossref_primary_10_1007_s11764_021_01114_7 crossref_primary_10_1007_s00066_012_0253_6 crossref_primary_10_1016_S0960_9776_11_70287_9 crossref_primary_10_1371_journal_pone_0263104 crossref_primary_10_1016_j_ijsu_2013_05_032
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.jamcollsurg.2007.07.015
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
EISSN	1879-1190
ExternalDocumentID	18155570
Genre	Multicenter Study Comparative Study Journal Article Research Support, N.I.H., Extramural
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GrantInformation_xml	– fundername: NCI NIH HHS grantid: R01 CA093772 – fundername: NCI NIH HHS grantid: U19 CA079689
GroupedDBID	--- --K --M -RU .55 .GJ .~1 0R~ 1B1 1CY 1KJ 1P~ 1~. 1~5 29L 2QL 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AAAAV AABNK AAEDT AAEDW AAGIX AAIKJ AAIQE AAJCS AAKOC AALRI AAOAW AAQFI AAQOH AAQQT AAQXK AAWTL AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABOCM ABPPZ ABPXF ABWVN ABXDB ABXYN ABZZY ACBMB ACDAQ ACGFO ACGFS ACILI ACIUM ACLDA ACRPL ACVFH ACXJB ACZKN ADBBV ADCNI ADEZE ADMUD ADNMO ADSXY AEBDS AEFWE AEKER AENEX AEUPX AEVXI AFBFQ AFEXH AFFNX AFNMH AFPUW AFTJW AGHFR AGQPQ AGUBO AGYEJ AHOMT AHQNM AHQVU AI. AIGII AITUG AJCLO AJNWD AJRQY AJZMW AKCTQ AKRWK ALKUP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX AOQMC ASPBG AVWKF AZFZN BKOJK BLXMC CGR CS3 CUY CVF DU5 EBS ECM EEVPB EIF EJD EO9 EP2 EP3 ERAAH EX3 F5P FCALG FDB FEDTE FGOYB FIRID FNPLU GBLVA HVGLF HZ~ IH2 IHE J1W J5H KOM L7B LXL LXN M41 MO0 N4W N9A NPM O-L O9- OAUVE OHT OVD OZT P-8 P-9 P2P PC. PQQKQ Q38 R2- RIG RLZ ROL RPZ SDF SDG SEL SES SEW SJN SPCBC SSZ TEORI UHB UV1 UXK VH1 WH7 WOW X7M ZGI ZRR ZXP ~G- 7X8 EFLBG ~HD
ID	FETCH-LOGICAL-c460t-80b3b646fe475b6ed02cc1214f37009b04c31d73f3ecb188afead845da5d78ac2
IEDL.DBID	7X8
ISICitedReferencesCount	137
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000252109200009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1879-1190
IngestDate	Sun Sep 28 10:00:11 EDT 2025 Tue Aug 05 11:35:18 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c460t-80b3b646fe475b6ed02cc1214f37009b04c31d73f3ecb188afead845da5d78ac2
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
PMID	18155570
PQID	70159453
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_70159453 pubmed_primary_18155570
PublicationCentury	2000
PublicationDate	2008-Jan 20080101
PublicationDateYYYYMMDD	2008-01-01
PublicationDate_xml	– month: 01 year: 2008 text: 2008-Jan
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of the American College of Surgeons
PublicationTitleAlternate	J Am Coll Surg
PublicationYear	2008
References	18501828 - J Am Coll Surg. 2008 Jun;206(3):1240
References_xml	– reference: 18501828 - J Am Coll Surg. 2008 Jun;206(3):1240
SSID	ssj0017096
Score	2.2969923
Snippet	The purpose of this study was to compare the rates of all-cause and breast cancer-specific mortality after breast-conserving surgery (BCS) only, BCS plus...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	66
SubjectTerms	Aged Aged, 80 and over Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - therapy Female Follow-Up Studies Humans Mastectomy - methods Neoplasm Staging Proportional Hazards Models Radiotherapy, Adjuvant - methods Retrospective Studies Survival Rate - trends Tamoxifen - therapeutic use Treatment Outcome United States - epidemiology
Title	Mortality impact of less-than-standard therapy in older breast cancer patients
URI	https://www.ncbi.nlm.nih.gov/pubmed/18155570 https://www.proquest.com/docview/70159453
Volume	206
WOSCitedRecordID	wos000252109200009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6qFfHiA1_1uYLXxTx2sxsQRMTiwYYeVHoL2UdE0aQ2rb_fmTzoSTwIIacEwjA782Xmm_kIubRBnMdWGSaVgR-USDimhBMMwDk23TId1dycl0eZJGoyicc9ct3NwiCtsouJdaC2pcEa-ZWEvBVzEd5MvxhqRmFvtRXQWCH9EIAMErrkZNlDkF6tzoVy2syHvLdOLpbsrvfsEw1dLWav7R5DuHzxO86s881w639fuk02W5xJbxvH2CE9V-ySZFSDbQDetJmOpGVOPyDWMSygs66sQJuhLHiooCWqeFON1PU5NegiM9ruYq32yPPw_unugbWCCszwyJtDNtKhjniUOy6Fjpz1AmP8wOd5KAFraY-b0LcyzENntK9UloOfKS5sJqxUmQn2yWpRFu6Q0MBAbve0LzT2JQMkUDnOA665zbSOzYCcd8ZJwWGxC5EVrlxUaWeeATlo7JtOm70aKYANgRvBjv5895hsNLwNLIWckH4OR9WdkjXzPX-rZme1H8A9GY9-AGE5vgM
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mortality+impact+of+less-than-standard+therapy+in+older+breast+cancer+patients&rft.jtitle=Journal+of+the+American+College+of+Surgeons&rft.au=Yood%2C+Marianne+Ulcickas&rft.au=Owusu%2C+Cynthia&rft.au=Buist%2C+Diana+S+M&rft.au=Geiger%2C+Ann+M&rft.date=2008-01-01&rft.eissn=1879-1190&rft.volume=206&rft.issue=1&rft.spage=66&rft_id=info:doi/10.1016%2Fj.jamcollsurg.2007.07.015&rft_id=info%3Apmid%2F18155570&rft_id=info%3Apmid%2F18155570&rft.externalDocID=18155570
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1879-1190&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1879-1190&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1879-1190&client=summon